Form 4: Agilon Health CAO Reports Routine Tax Withholding
Insider Transaction Report
Chief Accounting Officer Timothy Gertsch reported the withholding of 147 shares of common stock to satisfy tax obligations.
Summary
- Timothy Gertsch, Chief Accounting Officer of agilon health, inc., executed a net settlement of restricted stock units.
- A total of 147 shares were withheld by the company to cover tax obligations related to the vesting of equity awards.
- The transactions occurred on April 14, 2026 (25 shares at $22.68) and April 15, 2026 (122 shares at $26.88).
- Following these transactions, the reporting person maintains a beneficial ownership of 14,177 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transaction related to tax withholding and does not reflect a change in the executive's outlook on the company.
Positives
- The transaction represents a routine tax withholding event rather than a discretionary open-market sale of shares.
Negatives
- None identified; this is a standard administrative procedure for equity compensation.
Risks
- None identified; this filing relates to internal tax compliance.
Future Outlook
Not applicable; this is a historical disclosure of a completed transaction.
Industry Context
StockSavvy.ai notes that net settlement of equity awards is a standard industry practice for executives to manage tax liabilities associated with the vesting of restricted stock units.
Comparison to Industry Standards
- The transaction follows standard corporate governance practices for executive compensation and tax withholding, consistent with peers in the healthcare services sector.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a non-discretionary tax withholding.
Next Steps
- None; the transaction is complete.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Transaction date for the withholding of 25 shares. |
| 04/15/2026 | Transaction date for the withholding of 122 shares. |
| 04/16/2026 | Filing date of the Form 4. |
Keywords
agilon health, AGL, insider trading, Form 4, equity compensation, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.